| Dr Daniel Thomas Mcdevitt, MD | |
|
1035 Southcrest Dr, Suite 250, Stockbridge, GA 30281-6118 | |
| (770) 996-9945 | |
| (770) 996-7355 |
| Full Name | Dr Daniel Thomas Mcdevitt |
|---|---|
| Gender | Male |
| Speciality | Vascular Surgery |
| Experience | 38 Years |
| Location | 1035 Southcrest Dr, Stockbridge, Georgia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1174676829 | NPI | - | NPPES |
| 1861090-012 | Other | GA | CIGNA |
| 581800973 | Other | GA | UNITED HEALTHCARE |
| 770001325 | Other | GA | MEDICARE RAILROAD |
| 281529 | Other | GA | WELLCARE CHOICE PLAN |
| 000546521C | Medicaid | GA | |
| 0486348 | Other | GA | AETNA |
| 52451306002 | Other | GA | BLUE CROSS BLUE SHIELD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2086S0129X | Surgery - Vascular Surgery | 037025 (Georgia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Piedmont Henry Hospital | Stockbridge, GA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Peachtree Vascular Specialists, P.c. | 6901897362 | 3 |
News Archive
Quintiles today announced the availability of anatomic pathology services through its central laboratory in Beijing, China, to help biopharmaceutical companies develop more effective cancer treatments. These services complement assay development, digital pathology and core lab offerings available through the facility to help customers comply with China's restrictions on tissue import/export.
The inclusion of biological uncertainty and the latest case data can significantly improve the prediction accuracy of standard epidemiological models of virus transmission, new research led by KAUST and the Kuwait College of Science and Technology (KCST) has shown.
Personal Genome Diagnostics, Inc., a leader in cancer genomics and pioneer in liquid biopsy, today reported that its non-invasive, pan-cancer plasma assay is being used in an important new clinical trial, Nivolumab, Ipilimumab in Patients With Hyper Mutated Cancers Detected in Blood, led by the Cancer Research Institute and Canadian Cancer Trials Group.
Apitope, the drug discovery and development company focused on treating the underlying cause of autoimmune diseases, today announces that the consortium, led by Apitope, which includes GSK Vaccines, Quintiles and KWS Biotest Limited, has been awarded prestigious Framework Programme 7 Health Innovation funding by the European Commission to develop its Graves' disease therapeutic vaccine, including a Phase I first-in-man study in Graves' disease patients.
› Verified 8 days ago
| Entity Name | Peachtree Vascular Specialists, P.c. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1366595068 PECOS PAC ID: 6901897362 Enrollment ID: O20040524000490 |
News Archive
Quintiles today announced the availability of anatomic pathology services through its central laboratory in Beijing, China, to help biopharmaceutical companies develop more effective cancer treatments. These services complement assay development, digital pathology and core lab offerings available through the facility to help customers comply with China's restrictions on tissue import/export.
The inclusion of biological uncertainty and the latest case data can significantly improve the prediction accuracy of standard epidemiological models of virus transmission, new research led by KAUST and the Kuwait College of Science and Technology (KCST) has shown.
Personal Genome Diagnostics, Inc., a leader in cancer genomics and pioneer in liquid biopsy, today reported that its non-invasive, pan-cancer plasma assay is being used in an important new clinical trial, Nivolumab, Ipilimumab in Patients With Hyper Mutated Cancers Detected in Blood, led by the Cancer Research Institute and Canadian Cancer Trials Group.
Apitope, the drug discovery and development company focused on treating the underlying cause of autoimmune diseases, today announces that the consortium, led by Apitope, which includes GSK Vaccines, Quintiles and KWS Biotest Limited, has been awarded prestigious Framework Programme 7 Health Innovation funding by the European Commission to develop its Graves' disease therapeutic vaccine, including a Phase I first-in-man study in Graves' disease patients.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Daniel Thomas Mcdevitt, MD 1035 Southcrest Dr, Suite 250, Stockbridge, GA 30281-6118 Ph: (770) 996-9945 | Dr Daniel Thomas Mcdevitt, MD 1035 Southcrest Dr, Suite 250, Stockbridge, GA 30281-6118 Ph: (770) 996-9945 |
News Archive
Quintiles today announced the availability of anatomic pathology services through its central laboratory in Beijing, China, to help biopharmaceutical companies develop more effective cancer treatments. These services complement assay development, digital pathology and core lab offerings available through the facility to help customers comply with China's restrictions on tissue import/export.
The inclusion of biological uncertainty and the latest case data can significantly improve the prediction accuracy of standard epidemiological models of virus transmission, new research led by KAUST and the Kuwait College of Science and Technology (KCST) has shown.
Personal Genome Diagnostics, Inc., a leader in cancer genomics and pioneer in liquid biopsy, today reported that its non-invasive, pan-cancer plasma assay is being used in an important new clinical trial, Nivolumab, Ipilimumab in Patients With Hyper Mutated Cancers Detected in Blood, led by the Cancer Research Institute and Canadian Cancer Trials Group.
Apitope, the drug discovery and development company focused on treating the underlying cause of autoimmune diseases, today announces that the consortium, led by Apitope, which includes GSK Vaccines, Quintiles and KWS Biotest Limited, has been awarded prestigious Framework Programme 7 Health Innovation funding by the European Commission to develop its Graves' disease therapeutic vaccine, including a Phase I first-in-man study in Graves' disease patients.
› Verified 8 days ago
Dr. Ahmad Ibn Nuriddin, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 1040 Eagles Landing Pkwy, Suite 100, Stockbridge, GA 30281 Phone: 770-474-7287 Fax: 770-389-3713 | |
Jarrod D Day, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 350 Country Club Dr, Suite A, Stockbridge, GA 30281 Phone: 770-692-4000 Fax: 770-692-2400 | |
Dr. Brian S Myers, M.D., F.A.C.S. Surgery Medicare: Accepting Medicare Assignments Practice Location: 1040 Eagles Landing Pkwy, Suite 100, Stockbridge, GA 30281 Phone: 770-474-7287 Fax: 770-389-3713 | |
Reema Mallick, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 1040 Eagle's Landing Parkway, Suite 100, Stockbridge, GA 30281 Phone: 770-474-7287 Fax: 770-389-3713 | |
Jose L. Fernandez-gerena, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 1040 Eagles Landing Parkway, Suite 100, Stockbridge, GA 30281 Phone: 770-474-7287 Fax: 770-389-3713 | |
Dr. Gregory L Erdelyan, M.D. Surgery Medicare: Medicare Enrolled Practice Location: 1104 Hospital Dr, Stockbridge, GA 30281 Phone: 678-289-2003 Fax: 678-289-0191 |